Health utilities in Chinese patients with coronary heart disease and impaired glucose tolerance (ACE): a longitudinal analysis of a randomized, double-blind, placebo-controlled trial

Benzer Materyaller

• Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial
  Yazar:: Holman, R, ve diğerleri
  Baskı/Yayın Bilgisi: (2017)
• Comparison of medical resources, costs, and health utilities among patients with CHD and impaired glucose tolerance in the Acarbose Cardiovascular Evaluation Trial (ACE)
  Yazar:: Mc Morrow, L, ve diğerleri
  Baskı/Yayın Bilgisi: (2018)
• Predicting heart failure events in patients with coronary heart disease and impaired glucose tolerance: insights from the Acarbose Cardiovascular Evaluation (ACE) trial
  Yazar:: Wamil, M, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Predicting risk for new-onset type 2 diabetes in Chinese people with coronary heart disease and impaired glucose tolerance
  Yazar:: Xu, S, ve diğerleri
  Baskı/Yayın Bilgisi: (2019)
• Comparison of medical resources and costs among patients with coronary heart disease and impaired glucose tolerance in the Acarbose Cardiovascular Evaluation trial
  Yazar:: Liam Mc Morrow, ve diğerleri
  Baskı/Yayın Bilgisi: (2024-02-01)